Marsella R et al. |
Investigation on the clinical efficacy and safety of 0.1% tacrolimus ointment (Protopic) in canine atopic dermatitis: a randomized, double-blinded, placebo-controlled, cross-over study. |
2004 |
Vet. Dermatol. |
pmid:15500481
|
Hilton H et al. |
Evaluation of four topical preparations for the treatment of cannon hyperkeratosis in a horse. |
2008 |
Vet. Dermatol. |
pmid:19055613
|
Marsella R and Nicklin CF |
Investigation on the use of 0.3% tacrolimus lotion for canine atopic dermatitis: a pilot study. |
2002 |
Vet. Dermatol. |
pmid:12174182
|
Banovic F et al. |
Therapeutic effectiveness of calcineurin inhibitors in canine vesicular cutaneous lupus erythematosus. |
2017 |
Vet. Dermatol. |
pmid:28439997
|
Rosenkrantz WS |
Pemphigus: current therapy. |
2004 |
Vet. Dermatol. |
pmid:15030557
|
Nell B et al. |
The effect of topical pimecrolimus on keratoconjunctivitis sicca and chronic superficial keratitis in dogs: results from an exploratory study. |
2005 Jan-Feb |
Vet Ophthalmol |
pmid:15644099
|
Berdoulay A et al. |
Effect of topical 0.02% tacrolimus aqueous suspension on tear production in dogs with keratoconjunctivitis sicca. |
2005 Jul-Aug |
Vet Ophthalmol |
pmid:16008701
|
Hafizi S et al. |
Differential effects of rapamycin, cyclosporine A, and FK506 on human coronary artery smooth muscle cell proliferation and signalling. |
2004 May-Jun |
Vascul. Pharmacol. |
pmid:15607500
|
Dissemond J et al. |
Successful treatment of stasis dermatitis with topical tacrolimus. |
2004 |
VASA |
pmid:15623206
|
Woodward RS et al. |
The long-term outcomes and costs of diabetes mellitus among renal transplant recipients: tacrolimus versus cyclosporine. |
2011 |
Value Health |
pmid:21315636
|
Christ B et al. |
Interactions of sildenafil and tacrolimus in men with erectile dysfunction after kidney transplantation. |
2001 |
Urology |
pmid:11597545
|
Harmon JD et al. |
Stuttering priapism in a liver transplant patient with toxic levels of fk506. |
1999 |
Urology |
pmid:10754131
|
Chkhotua AB et al. |
Kidney transplantation from living-unrelated donors: comparison of outcome with living-related and cadaveric transplants under current immunosuppressive protocols. |
2003 |
Urology |
pmid:14665344
|
Ebert AK et al. |
[Topical therapy of balanitis xerotica obliterans in childhood. Long-term clinical results and an overview]. |
2007 |
Urologe A |
pmid:17994212
|
|
[Tacrolimus--a new perspective in kidney transplantation]. |
1996 |
Urologe A |
pmid:9022401
|
Nomura T et al. |
Enhancement by cyclosporin A of taxol-induced apoptosis of human urinary bladder cancer cells. |
2002 |
Urol. Res. |
pmid:12086014
|
Hwang MT and Goldfarb DS |
Uric acid stones following hepatic transplantation. |
2004 |
Urol. Res. |
pmid:15565437
|
Veroux P et al. |
Severe neurotoxicity in tacrolimus-treated living kidney transplantation in two cases. |
2003 |
Urol. Int. |
pmid:14646448
|
Pichler R et al. |
De novo renal cell carcinoma in a kidney allograft with focus on contrast-enhanced ultrasound. |
2014 |
Urol. Int. |
pmid:25115614
|
Naderi GH et al. |
Tacrolimus rescue therapy for corticosteroid-resistant and polyclonal antibody-resistant kidney allograft rejections. |
2009 |
Urol J |
pmid:19241339
|